Versant Ventures — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Chinook Therapeutics U.SFeb 2019SEC filingmedium confidence
Seattle, US
Sam Hall(Director)Eric Dobmeier(Executive Officer, Director)
BoardSrini Akkaraju(Director)Jeremy Caldwell(Director)
Board seatJerel Davis· per SEC Form D · $65M raise · filed Aug 2019
Turnstone Biologicsturnstonebio.comJan 2019SEC filingmedium confidence
BiotechNew York, US
Jose Manuel Otero(Executive Officer)Robert Gould(Director)Jane Henderson(Executive Officer)Michael Burgess(Executive Officer)Stefan Larson(Director)Patrick Machado(Director)
Board seatBrad BolzonJerel Davis· per SEC Form D · $42.1M raise · filed Jan 2019
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.